AGENUS INC (AGEN)

↓ Download CSV

CIK 0001098972 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, AGENUS INC reported revenue of $114.20M, up 10.4% from the prior year. The company ran a net loss, with a net margin of -2.7%.

Key ratios (FY2025)

-17.7%
Operating margin
-2.7%
Net margin
+10.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$114.20M$103.46M$156.31M$98.02M$295.67M$88.17M$150.05M$36.78M$42.88M$22.57M
Cost of Revenue$1.02M$486.0K$3.11M$10.57M$3.47M$2.35M
Operating Income-$20.17M-$120.47M-$159.55M-$179.43M$25.75M-$117.23M-$70.14M-$123.82M-$103.80M-$107.48M
Net Income-$3.08M-$232.27M-$257.44M-$230.66M-$28.72M-$182.89M-$111.56M-$162.04M-$120.69M-$127.00M
EPS (Diluted)$0.00$-10.59$-13.75$-15.64$-0.11$-1.05
Total Assets$226.80M$226.27M$313.91M$413.56M$465.96M$214.51M$155.34M$136.40M$138.40M$156.99M
Shareholders' Equity-$271.11M-$326.38M-$160.33M-$61.28M$34.44M-$203.67M-$225.36M-$172.47M-$75.82M-$39.13M
Cash & Equivalents$3.00M$40.44M$76.11M$178.67M$291.93M$99.87M$61.81M$53.05M$60.19M$71.45M
Operating Cash Flow-$77.19M-$158.31M-$224.20M-$175.37M$10.14M-$139.10M-$18.68M-$131.09M-$94.23M-$79.96M
Capital Expenditures$6.0K$576.0K$9.95M$53.06M$33.81M$3.47M$4.66M$3.60M$3.12M$12.52M
Shares Outstanding29.73M21.47M17.89M14.09M228.9K172.5K